383,089 Shares in Synopsys, Inc. $SNPS Bought by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 383,089 shares of the semiconductor company’s stock, valued at approximately $170,886,000.

A number of other hedge funds have also bought and sold shares of SNPS. Sankala Group LLC purchased a new stake in shares of Synopsys in the fourth quarter valued at $25,000. Elevation Wealth Partners LLC boosted its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. Osbon Capital Management LLC bought a new position in Synopsys during the 2nd quarter valued at about $25,000. IMG Wealth Management Inc. bought a new position in Synopsys during the 2nd quarter valued at about $28,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in Synopsys in the 4th quarter worth about $28,000. Institutional investors own 85.47% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Stock Performance

Synopsys stock opened at $394.51 on Tuesday. The company has a 50 day moving average price of $418.53 and a 200-day moving average price of $439.92. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79. The company has a market capitalization of $75.54 billion, a PE ratio of 91.32, a P/E/G ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter in the previous year, the business earned $3.67 earnings per share. Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on SNPS. Stifel Nicolaus raised their price objective on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research note on Wednesday, August 19th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Berenberg Bank set a $633.00 price target on Synopsys in a research note on Wednesday, May 27th. Finally, Citigroup boosted their price objective on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus target price of $563.59.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.